Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Cardiac 123I-mIBG SPECT Imaging
NCT02043522Phase 3Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Dec 2013
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by University of Ottawa Heart Institute. Primary endpoint: Heart to Calibration Ratios at 4 hours. Started Dec 2013; status: completed.
Beyond the preview
Go deeper on NCT02043522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043522.